{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:30:14Z","timestamp":1773919814489,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:00:00Z","timestamp":1512518400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Leiden University Medical Center (LUMC)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00277-017-3167-7","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T23:23:12Z","timestamp":1512516192000},"page":"255-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens"],"prefix":"10.1007","volume":"97","author":[{"given":"L. E. M.","family":"Oosten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E. D.","family":"Chamuleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. W.","family":"Thielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. C.","family":"de Wreede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Siemes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K.","family":"Doorduijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. S.","family":"Smeekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Hardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. W.","family":"Baars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M. P.","family":"Demandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. B. C.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nijland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. W.","family":"van Imhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Uyl-de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"issue":"18","key":"3167_CR1","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1016\/j.ejca.2004.09.004","volume":"40","author":"EG Boerma","year":"2004","unstructured":"Boerma EG, van Imhoff GW, Appel IM, Veeger NJ, Kluin PM, Kluin-Nelemans JC (2004) Gender and age-related differences in Burkitt lymphoma\u2014epidemiological and clinical data from The Netherlands. Eur J Cancer 40(18):2781\u20132787. https:\/\/doi.org\/10.1016\/j.ejca.2004.09.004","journal-title":"Eur J Cancer"},{"issue":"10","key":"3167_CR2","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","volume":"104","author":"KA Blum","year":"2004","unstructured":"Blum KA, Lozanski G, Byrd JC (2004) Adult Burkitt leukemia and lymphoma. Blood 104(10):3009\u20133020. https:\/\/doi.org\/10.1182\/blood-2004-02-0405","journal-title":"Blood"},{"issue":"6","key":"3167_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2141.2011.08877.x","volume":"156","author":"DC Linch","year":"2012","unstructured":"Linch DC (2012) Burkitt lymphoma in adults. Br J Haematol 156(6):693\u2013703. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08877.x","journal-title":"Br J Haematol"},{"issue":"5","key":"3167_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00001622-200409000-00003","volume":"16","author":"YL Kasamon","year":"2004","unstructured":"Kasamon YL, Swinnen LJ (2004) Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol 16(5):429\u2013435","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"3167_CR5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","volume":"85","author":"C Soussain","year":"1995","unstructured":"Soussain C, Patte C, Ostronoff M, Delmer A, Rigalhuguet F, Cambier N, Leprise PY, Francois S, Conymakhoul P, Harousseau JL, Janvier M, Chauvenet L, Witz F, Pico J (1995) Small noncleaved cell lymphoma and leukemia in adults-a retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 85(3):664\u2013674","journal-title":"Blood"},{"issue":"12","key":"3167_CR6","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/annonc\/mdi403","volume":"16","author":"M Divine","year":"2005","unstructured":"Divine M, Casassus P, Koscielny S, Bosq J, Sebban C, Le Maignan C, Stamattoulas A, Dupriez B, Raphael M, Pico JL, Ribrag V, Goelams G (2005) Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol. Ann Oncol 16(12):1928\u20131935. https:\/\/doi.org\/10.1093\/annonc\/mdi403","journal-title":"Ann Oncol"},{"issue":"2","key":"3167_CR7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Loffler H, Fonatsch C, Rieder H, Heil G, Heinze B, Arnold R, Hossfeld D, Buchner T, Koch P, Freund M, Hiddemann W, Maschmeyer G, Heyll A, Aul C, Faak T, Kuse R, Ittel TH, Gramatzki M, Diedrich H, Kolbe K, Fuhr HG, Fischer K, SchadeckGressel C, Weiss A, Strohscheer I, Metzner B, Fabry U, Gokbuget N, Volkers B, Messerer D, Uberla K (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87(2):495\u2013508","journal-title":"Blood"},{"issue":"6","key":"3167_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/sj.leu.2403733","volume":"19","author":"GW Imhoff van","year":"2005","unstructured":"van Imhoff GW, van der Holt B, MacKenzie MA, Ossenkoppele GJ, Wijermans PW, Kramer MHH, van\u2019t Veer MB, Schouten HC, Kooy MV, van Oers MHJ, Raemaekers JMM, Sonneveld P, Meulendijks LAMH, Kluin PM, Kluin-Nelemans HC, Verdonck LF (2005) Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 19(6):945\u2013952. https:\/\/doi.org\/10.1038\/sj.leu.2403733","journal-title":"Leukemia"},{"issue":"8","key":"3167_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","volume":"13","author":"GM Mead","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Norbert P, Guarnaccia C, Lewis MS, McKendrick J, Stenning SP, Wright D, Collaborators UL (2002) An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 13(8):1264\u20131274. https:\/\/doi.org\/10.1093\/annonc\/mdf253","journal-title":"Ann Oncol"},{"issue":"26","key":"3167_CR10","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1182\/blood-2014-03-563627","volume":"124","author":"D Hoelzer","year":"2014","unstructured":"Hoelzer D, Walewski J, Dohner H, Viardot A, Hiddemann W, Spiekermann K, Serve H, Duhrsen U, Huttmann A, Thiel E, Dengler J, Kneba M, Schaich M, Schmidt-Wolf IG, Beck J, Hertenstein B, Reichle A, Domanska-Czyz K, Fietkau R, Horst HA, Rieder H, Schwartz S, Burmeister T, Gokbuget N, German Multicenter Study Group for Adult Acute Lymphoblastic L (2014) Improved outcome of adult Burkitt lymphoma\/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood 124(26):3870\u20133879. https:\/\/doi.org\/10.1182\/blood-2014-03-563627","journal-title":"Blood"},{"issue":"6","key":"3167_CR11","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1182\/blood-2008-03-145128","volume":"112","author":"GM Mead","year":"2008","unstructured":"Mead GM, Barrans SL, Qian WD, Walewski J, Radford JA, Wolf M, Clawson SM, Stenning SP, Yule CL, Jack AS, Cli UNCRIL, Lymphoma AL (2008) A prospective clinicopathologic study of dose-modified CODOX-M\/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC\/NCRI LY10 trial). Blood 112(6):2248\u20132260. https:\/\/doi.org\/10.1182\/blood-2008-03-145128","journal-title":"Blood"},{"issue":"4","key":"3167_CR12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17(4):1244","journal-title":"J Clin Oncol"},{"issue":"5","key":"3167_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on L (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579\u2013586. https:\/\/doi.org\/10.1200\/JCO.2006.09.2403","journal-title":"J Clin Oncol"},{"key":"3167_CR14","unstructured":"CBS Statistics Netherlands Consumer prices (2016) http:\/\/statline.cbs.nl\/StatWeb\/publication\/?VW=T&DM=SLEN&PA=71311eng&LA=EN"},{"key":"3167_CR15","unstructured":"Royal Dutch Pharmacists Association Knowledge Bank. https:\/\/www.knmp.nl\/producten-en-diensten\/knmp-kennisbank"},{"key":"3167_CR16","unstructured":"Hakkaart-van Roijen L, van der Linden N, Bouwamans C, Kanters T, Swan Tan S (2015) Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg. Bijlage 1. https:\/\/www.zorginstituutnederland.nl\/binaries\/zinl\/documenten\/publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg\/Richtlijn+voor+het+uitvoeren+van+economische+evaluaties+in+de+gezondheidszorg+%28verdiepingsmodules%29.pdf"},{"issue":"3","key":"3167_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.leukres.2012.09.018","volume":"37","author":"A Leunis","year":"2013","unstructured":"Leunis A, Blommestein HM, Huijgens PC, Blijlevens NM, Jongen-Lavrencic M, Uyl-de Groot CA (2013) The costs of initial treatment for patients with acute myeloid leukemia in the Netherlands. Leuk Res 37(3):245\u2013250. https:\/\/doi.org\/10.1016\/j.leukres.2012.09.018","journal-title":"Leuk Res"},{"issue":"1","key":"3167_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/jcpt.12020","volume":"38","author":"JG Gaultney","year":"2013","unstructured":"Gaultney JG, Franken MG, Tan SS, Redekop WK, Huijgens PC, Sonneveld P, Uyl-de Groot CA (2013) Real-world health care costs of relapsed\/refractory multiple myeloma during the era of novel cancer agents. J Clin Pharm Ther 38(1):41\u201347. https:\/\/doi.org\/10.1111\/jcpt.12020","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"3167_CR19","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00277-012-1530-2","volume":"91","author":"HM Blommestein","year":"2012","unstructured":"Blommestein HM, Verelst SG, Huijgens PC, Blijlevens NM, Cornelissen JJ, Uyl-de Groot CA (2012) Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study. Ann Hematol 91(12):1945\u20131952. https:\/\/doi.org\/10.1007\/s00277-012-1530-2","journal-title":"Ann Hematol"},{"key":"3167_CR20","doi-asserted-by":"publisher","unstructured":"(1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. The N Engl J Med 329 (14):987\u2013994. doi: https:\/\/doi.org\/10.1056\/NEJM199309303291402","DOI":"10.1056\/NEJM199309303291402"},{"issue":"20","key":"3167_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"11","key":"3167_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00277-009-0729-3","volume":"88","author":"MK Choi","year":"2009","unstructured":"Choi MK, Jun HJ, Lee SY, Kim KH, Lim DH, Kim K, Ko YH, Kim WS, Kim SJ (2009) Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea. Ann Hematol 88(11):1099\u20131106. https:\/\/doi.org\/10.1007\/s00277-009-0729-3","journal-title":"Ann Hematol"},{"issue":"4","key":"3167_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/Ajh.21648","volume":"85","author":"S Tauro","year":"2010","unstructured":"Tauro S, Cochrane L, Lauritzsen GF, Baker L, Delabie J, Roberts C, Mahendra P, Holte H (2010) Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<\u200950 years): a comparison of two adapted BFM protocols. Am J Hematol 85(4):261\u2013263. https:\/\/doi.org\/10.1002\/Ajh.21648","journal-title":"Am J Hematol"},{"issue":"12","key":"3167_CR24","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.1002\/Ajh.22165","volume":"86","author":"M Pohlen","year":"2011","unstructured":"Pohlen M, Gerth HU, Liersch R, Koschmieder S, Mesters RM, Kessler T, Appelmann I, Muller-Tidow C, Berdel WE (2011) Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL\/NHL 2002 protocol) in Burkitt\u2019s and primary mediastinal large B-cell lymphoma. Am J Hematol 86(12):E61\u2013E64. https:\/\/doi.org\/10.1002\/Ajh.22165","journal-title":"Am J Hematol"},{"issue":"11","key":"3167_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3324\/haematol.2013.086827","volume":"98","author":"T Intermesoli","year":"2013","unstructured":"Intermesoli T, Rambaldi A, Rossi G, Delaini F, Romani C, Pogliani EM, Pagani C, Angelucci E, Terruzzi E, Levis A, Cassibba V, Mattei D, Gianfaldoni G, Scattolin AM, Di Bona E, Oldani E, Parolini M, Gokbuget N, Bassan R (2013) High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 98(11):1718\u20131725. https:\/\/doi.org\/10.3324\/haematol.2013.086827","journal-title":"Haematologica"},{"issue":"4","key":"3167_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/1042819031000141301","volume":"45","author":"A Lacasce","year":"2004","unstructured":"Lacasce A, Howard O, Lib S, Fisher D, Weng A, Neuberg D, Shipp M (2004) Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma 45(4):761\u2013767. https:\/\/doi.org\/10.1080\/1042819031000141301","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"3167_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12185-010-0728-0","volume":"92","author":"D Maruyama","year":"2010","unstructured":"Maruyama D, Watanabe T, Maeshima AM, Nomoto J, Taniguchi H, Azuma T, Mori M, Munakata W, Kim SW, Kobayashi Y, Matsuno Y, Tobinai K (2010) Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)\/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. Int J Hematol 92(5):732\u2013743. https:\/\/doi.org\/10.1007\/s12185-010-0728-0","journal-title":"Int J Hematol"},{"issue":"8","key":"3167_CR28","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/annonc\/mdq677","volume":"22","author":"JA Barnes","year":"2011","unstructured":"Barnes JA, LaCasce AS, Feng Y, Toomey CE, Neuberg D, Michaelson JS, Hochberg EP, Abramson JS (2011) Evaluation of the addition of rituximab to CODOX-M\/IVAC for Burkitt\u2019s lymphoma: a retrospective analysis. Ann Oncol 22(8):1859\u20131864. https:\/\/doi.org\/10.1093\/annonc\/mdq677","journal-title":"Ann Oncol"},{"issue":"7","key":"3167_CR29","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/annonc\/mdt058","volume":"24","author":"T Wasterlid","year":"2013","unstructured":"Wasterlid T, Brown PN, Hagberg O, Hagberg H, Pedersen LM, D'Amore F, Jerkeman M (2013) Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. Ann Oncol 24(7):1879\u20131886. https:\/\/doi.org\/10.1093\/annonc\/mdt058","journal-title":"Ann Oncol"},{"issue":"1","key":"3167_CR30","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.fertnstert.2011.10.040","volume":"97","author":"CR Gracia","year":"2012","unstructured":"Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, Vance A, Ginsberg JP (2012) Impact of cancer therapies on ovarian reserve. Fertil Steril 97(1):134\u2013140 e131. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.10.040","journal-title":"Fertil Steril"},{"issue":"1","key":"3167_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/ejh.12284","volume":"94","author":"E Carrillo-Cruz","year":"2015","unstructured":"Carrillo-Cruz E, Marin-Oyaga VA, Sole Rodriguez M, Borrego-Dorado I, de la Cruz VF, Quiroga Cantero E, Manzanares Perez M, Capote FJ, Ramirez Sanchez MJ, Espigado Tocino I, Perez-Vega H, Vazquez-Albertino R, Perez-Simon JA (2015) Role of 18F-FDG-PET\/CT in the management of Burkitt lymphoma. Eur J Haematol 94(1):23\u201330. https:\/\/doi.org\/10.1111\/ejh.12284","journal-title":"Eur J Haematol"},{"issue":"3","key":"3167_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MNM.0b013e328334fc14","volume":"31","author":"R Riad","year":"2010","unstructured":"Riad R, Omar W, Sidhom I, Zamzam M, Zaky I, Hafez M, Abdel-Dayem HM (2010) False-positive F-18 FDG uptake in PET\/CT studies in pediatric patients with abdominal Burkitt\u2019s lymphoma. Nucl Med Commun 31(3):232\u2013238. https:\/\/doi.org\/10.1097\/MNM.0b013e328334fc14","journal-title":"Nucl Med Commun"},{"issue":"8","key":"3167_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"AJ Peniket","year":"2003","unstructured":"Peniket AJ, de Elvira MCR, Taghipour G, Cordonnier C, Gluckman E, de Witte T, Santini G, Blaise D, Greinix H, Ferrant A, Cornelissen J, Schmitz N, Goldstone AH, Registry EL (2003) An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transpl 31(8):667\u2013678. https:\/\/doi.org\/10.1038\/sj.bmt.1703891","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"3167_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbmt.2012.11.016","volume":"19","author":"LV Maramattom","year":"2013","unstructured":"Maramattom LV, Hari PN, Burns LJ, Carreras J, Arcese W, Cairo MS, Costa LJ, Fenske TS, Lill M, Freytes CO, Gale RP, Gross TG, Hale GA, Hamadani M, Holmberg LA, Hsu JW, Inwards DJ, Lazarus HM, Marks DI, Maloney DG, Maziarz RT, Montoto S, Rizzieri DA, Wirk B, Gajewski JL (2013) Autologous and allogeneic transplantation for Burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 19(2):173\u2013179. https:\/\/doi.org\/10.1016\/j.bbmt.2012.11.016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"3167_CR35","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","volume":"369","author":"K Dunleavy","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH (2013) Low-intensity therapy in adults with Burkitt\u2019s lymphoma. N Engl J Med 369(20):1915\u20131925. https:\/\/doi.org\/10.1056\/NEJMoa1308392","journal-title":"N Engl J Med"},{"key":"3167_CR36","doi-asserted-by":"crossref","unstructured":"Dunleavy Kea (2015) Risk-adapted therapy in adults with Burkitt lymphoma: preliminary report of a multicenter prospective phase II study of DA-EPOCH-R. Blood (ASH 2015) 126 (342)","DOI":"10.1182\/blood.V126.23.342.342"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3167-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T20:58:25Z","timestamp":1603486705000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3167-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,6]]}}}